APA

Bloemendal H. J., de Boer H. C., Koop E. A., van Dongen A. J., Goldschmeding R., Landman W. J. M., Logtenberg T., Gebbink M. F. B. G. & Voest E. E. (20040930). Activated vitronectin as a target for anticancer therapy with human antibodies. : Cancer immunology, immunotherapy : CII.

Chicago

Bloemendal Haiko J, de Boer Hetty C, Koop Elianne A, van Dongen Alice J, Goldschmeding Roel, Landman Wil J M, Logtenberg Ton, Gebbink Martijn F B G and Voest Emile E. 20040930. Activated vitronectin as a target for anticancer therapy with human antibodies. : Cancer immunology, immunotherapy : CII.

Harvard

Bloemendal H. J., de Boer H. C., Koop E. A., van Dongen A. J., Goldschmeding R., Landman W. J. M., Logtenberg T., Gebbink M. F. B. G. and Voest E. E. (20040930). Activated vitronectin as a target for anticancer therapy with human antibodies. : Cancer immunology, immunotherapy : CII.

MLA

Bloemendal Haiko J, de Boer Hetty C, Koop Elianne A, van Dongen Alice J, Goldschmeding Roel, Landman Wil J M, Logtenberg Ton, Gebbink Martijn F B G and Voest Emile E. Activated vitronectin as a target for anticancer therapy with human antibodies. : Cancer immunology, immunotherapy : CII. 20040930.